Pharmacopeia Issues Plea to Block Shareholder s Bid to Dash Eos Acquisition | GenomeWeb

LOS ANGELES, Dec. 28 - Pharmacopeia on Friday issued a plea to shareholders asking them to ignore a formal request by a group of stockholders to prevent the company from acquiring Eos Biotechnology.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.